6/2 2021

Centivax and U.S. Naval Medical Research Center announce strategic partnership to initiate clinical development of a broad-spectrum injectable for COVID-19, with $4.2M from the Henry Jackson Foundation

2023-05-18T08:28:25-04:00June 2nd, 2021|ATI in the News|

"With discovery research supported by Medical Technology Enterprise Consortium, and now clinical development supported by our remarkable collaboration with the Naval Medical Research Center, this biotech-government partnership is proud to advance this molecule into clinical development and closer to the patients and doctors that need a better medicine to end the pandemic."

5/26 2021

MTEC member researches treatment of septic shock, the cause of 70% of COVID deaths

2023-05-18T08:28:41-04:00May 26th, 2021|Success Stories|

Vivacelle Bio, Inc., a non-traditional small business and Medical Technology Enterprise Consortium (MTEC) member, was awarded $5.3 million to research treatment of septic shock.

Go to Top